Open original FDA record ↗Recall record
- FDA identifier
- Z-0235-2024
- Company in FDA record
- Pulmonx, Corp.
- FDA classification date
- Nov 6, 2023
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Endobronchial implant devices may have been labeled with a shortened expiration date but they can be used until the correct expiration date: 08 December 2024.
Source facts
- Action
- On 8/31/23, correction notices were emailed to customers who were asked to do the following: 1) The affected lot can be used without risk to the patient until 08 December 2024. In addition, this lot was manufactured on 2021-12-08. 2) Check your inventory and keep this letter with any remaining product of the affected lot to support the corrected manufacture and expiration date. 3) Send a response email acknowledging receipt that includes the number of affected devices remaining at your site. Customers with questions can call 650-743-6848.
- Initiated
- 2023-08-31
- Root cause
- Error in labeling
- Distribution
- US: TN, WV, AR, PA, VA, NC, IL, IA, MA, NY, NJ, WA, CO, OR, MI, FL, OH, TX, OK, AZ, NV, WI
- Recall number
- Z-0235-2024
- Recall status
- Open, Classified
- CDRH record ID
- 203609
- FDA classified
- 2023-11-06
- Recall event number
- 93179